These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12
1937 results:

  • 1. Unveiling new chapters in medullary thyroid carcinoma therapy: advances in molecular genetics and targeted treatment strategies.
    Huai JX; Wang F; Zhang WH; Lou Y; Wang GX; Huang LJ; Sun J; Zhou XQ
    Front Endocrinol (Lausanne); 2024; 15():1484815. PubMed ID: 39439561
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sporadic and Familial Medullary Thyroid Carcinoma: A retrospective Single Center Study on Presentation and Outcome.
    Prinzi A; Vella V; Bosco A; Mirone A; Russo M; Piticchio T; Di Benedetto G; Bartoloni G; Frasca F; Malandrino P
    Endocr Res; 2024; 49(4):179-185. PubMed ID: 39419111
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular genetics, therapeutics and ret inhibitor resistance for medullary thyroid carcinoma and future perspectives.
    Zhang Y; Zheng WH; Zhou SH; Gu JL; Yu Q; Zhu YZ; Yan YJ; Zhu Z; Shang JB
    Cell Commun Signal; 2024 Sep; 22(1):460. PubMed ID: 39342195
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid
    Stanescu LS; Ghemigian A; Ciobica ML; Nistor C; Ciuche A; Radu AM; Sandru F; Carsote M
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337252
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PRAP study-partial versus radical adrenalectomy in hereditary pheochromocytomas.
    Xu K; Langenhuijsen JF; Viëtor CL; Feelders RA; van Ginhoven TM; Elhassan YS; Bioletto F; Parasiliti-Caprino M; Zandee WT; Kruijff S; Backman S; Åkerström T; Pamporaki C; Bechmann N; Lussey-Lepoutre C; Canu L; Steenaard RV; Driessens N; Velema M; Dreijerink KMA; Engelsman AF; Timmers HJLM; de Laat JM
    Eur J Endocrinol; 2024 Aug; 191(3):345-353. PubMed ID: 39171965
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clues for Early Diagnosis of men2b Syndrome Before Medullary Thyroid Carcinoma.
    Taylor-Miller T; Tucker K; Sugo E; Anazodo A; Mowat D
    Pediatrics; 2024 Sep; 154(3):. PubMed ID: 39148481
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fluctuating obliterative bronchiolitis in ret-mutant medullary thyroid cancer patient treated with selpercatinib.
    Gambale C; Prete A; Romei C; Celi A; Elisei R; Matrone A
    Eur Thyroid J; 2024 Oct; 13(5):. PubMed ID: 39136571
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High success rate of first proficiency testing for ret fusions and ret mutations in lung and thyroid cancer samples by various methods.
    Siebolts U; Pappesch R; Bauer M; Dietmaier W; Ernst M; Haak A; Hartmann N; Ilm K; Kalbourtzis S; Krause T; Kazdal D; Schorle H; Utpatel K; Merkelbach-Bruse S
    Virchows Arch; 2024 Sep; 485(3):519-526. PubMed ID: 39120655
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Durability of Response With Selpercatinib in Patients With
    Wirth LJ; Brose MS; Subbiah V; Worden F; Solomon B; Robinson B; Hadoux J; Tomasini P; Weiler D; Deschler-Baier B; Tan DSW; Maeda P; Lin Y; Singh R; Bayt T; Drilon A; Cassier PA
    J Clin Oncol; 2024 Sep; 42(27):3187-3195. PubMed ID: 39094065
    [No Abstract]    [Full Text] [Related]  

  • 10. Pheochromocytoma/paraganglioma type 5 syndrome as a cause of secondary hypertension in a Colombian patient: case report.
    Morales J; Arturo D; Folleco M
    Biomedica; 2024 May; 44(Sp. 1):18-26. PubMed ID: 39079135
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review.
    Jo KH; Lee J; Yoo J; Kim HS; Kim ES; Han JH; Jang YS; Yun JS; Son JW; Yoo SJ; Lee SH; Lim DJ; Kwon HS; Lee S; Moon S; Kim M
    Ann Lab Med; 2024 Nov; 44(6):591-597. PubMed ID: 39069753
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B.
    Greenberg LA
    Prim Care; 2024 Sep; 51(3):483-494. PubMed ID: 39067973
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biomarker identification of medullary thyroid carcinoma from gene expression profiles considering without-treatment and with-treatment studies-A bioinformatics approach.
    Loganathan T; George Priya Doss C
    Adv Protein Chem Struct Biol; 2024; 142():367-396. PubMed ID: 39059991
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Endocrine; 2024 Sep; 85(3):1091-1095. PubMed ID: 39003661
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ganglioneuromatous polyposis associated with type 2 B multiple endocrine neoplasia (MEN 2B) - case report.
    Rycyk-Bojarzyńska A; Kasztelan-Szczerbińska B; Cichoż-Lach H; Jargieło A
    Ann Agric Environ Med; 2024 Jun; 31(2):302-305. PubMed ID: 38940117
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Generation of Myeloid-Derived Suppressor cells Mediated by MicroRNA-125a-5p in Melanoma.
    Lasser S; Ozbay Kurt FG; Fritz L; Gutzeit N; De La Torre C; Altevogt P; Utikal J; Umansky V
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928399
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Critically evaluated key points on hereditary medullary thyroid carcinoma.
    Zhang D; Liang N; Sun H; Frattini F; Sui C; Yang M; Wang H; Dionigi G
    Front Endocrinol (Lausanne); 2024; 15():1412942. PubMed ID: 38919477
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparative Performance Analysis of Idylla and Archer in the Detection of Gene Fusions in Spitzoid Melanocytic tumors.
    Ebbelaar CF; van Dijk M; Breimer GE; Meijers RWJ; Klein LBC; Petronilia MM; de Leng WWJ; Blokx WAM; Jansen AML;
    Mod Pathol; 2024 Aug; 37(8):100538. PubMed ID: 38880351
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma.
    Gigliotti BJ; Brooks JA; Wirth LJ
    Mol Cell Endocrinol; 2024 Oct; 592():112295. PubMed ID: 38871174
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The role of the adrenalectomy in the management of pheochromocytoma: the experience of a Portuguese referral center.
    Carvalho IC; Machado MVB; Morais JP; Carvalho F; Barbosa E; Barbosa J
    Endocrine; 2024 Oct; 86(1):409-416. PubMed ID: 38849646
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 97.